# Is compounded semaglutide the same as Wegovy?

> Compounded semaglutide is not the same as Wegovy. It is not FDA-approved, and Wegovy's trial results do not transfer to it. See how the two differ.

Source: https://livingplusrx.com/compounded-semaglutide-vs-wegovy/
Publisher: Living+ Rx (livingplusrx.com)
Author: Living+
Published: 2026-11-10
Last updated: 2026-11-10

No. Wegovy is an FDA-approved drug and compounded semaglutide is not, so FDA never reviewed a compounded version for safety, effectiveness or quality before it was sold. Wegovy’s label reports a trial of 1,961 adults. Compounded drugs do not go through that review at all, and no result from Wegovy’s trials can be carried over to them.

The word semaglutide on both labels is where the confusion starts, and some of that confusion has been manufactured. On March 3, 2026, FDA announced 30 warning letters to telehealth companies, and the main violation it named was claims implying sameness with FDA-approved products. Its guidance to those companies lists phrases it treats as false or misleading, including calling a compounded drug a generic version of an approved drug or the same as one. If a website told you the two were identical, FDA has a view about that website.

“Generic” is the other word to watch. FDA says compounded drugs are not the same as FDA-approved generics.

## How do compounded semaglutide and Wegovy differ?

| | Wegovy | Compounded semaglutide |
| --- | --- | --- |
| FDA approval | Yes. FDA approved it for weight reduction. | No. Compounded drugs are not FDA-approved. |
| Review before sale | Yes. FDA reviewed it before it reached the market. | No. FDA does not review it for safety, effectiveness or quality first. |
| Maker | Novo Nordisk. One manufacturer holds the approval. | A compounding pharmacy or outsourcing facility. The maker varies. |
| Trial results | Yes. The label prints them. | None transfer. Wegovy’s results belong to Wegovy. |
| Form | Single-dose pen or tablet. The label sets the doses. | May come in a multi-dose vial. Doses may be measured by hand. |

The trial row deserves more than a table cell. In the Wegovy study, adults on the 2.4 mg injection had a mean weight decrease of 14.9% at week 68, compared with 2.4% on placebo. Those figures describe Wegovy, in that trial, in those patients. They say nothing about how any compounded product performs, and a site that borrows them for one is doing what FDA has written to companies about.

The vial row matters too, for a duller reason. FDA has received reports of dosing errors with compounded semaglutide injections, some requiring hospitalization, where patients measured the dose incorrectly or a provider miscalculated it. A pen with a fixed dose does not ask you to read a syringe at 7 a.m.

As of May 31, 2026, FDA had 990 adverse event reports tied to compounded semaglutide, and it notes that underreporting is likely. A report count cannot give you a rate, and a report does not prove the drug caused the problem. Two other items on FDA’s page are more specific. Some fraudulent products carry false information on the label. FDA also says semaglutide sodium and semaglutide acetate are different active ingredients from those in the approved drugs. It says it is not aware of any lawful basis for using them in compounding.

## Why would a provider prescribe compounded semaglutide at all?

During the national shortage, compounders had more room to operate. FDA determined the semaglutide injection shortage was resolved on February 21, 2025, and the enforcement discretion that came with it has since ended. FDA still says a compounded drug might be appropriate if a patient’s medical need cannot be met by an FDA-approved drug.

At Living+, that is the condition. A compounded product is prescribed only when the licensed provider determines an FDA-approved product is not clinically suitable and documents why. You do not pick it from a menu. The provider decides, may decide no, and if the answer is no you are not charged.

Price is what brings most of this up, so here are the two numbers. Living+ lists [compounded semaglutide injection](https://livingplusrx.com/semaglutide/) at $197 a month, flat. Novo Nordisk’s self-pay page lists standard Wegovy pens at $349 a month after an introductory offer. That gap is a price difference between two different products, and it should be read that way.

For anyone weighing this, the fair comparison is what each one can show you. Wegovy can show a label and its trials. With a compounded product you can ask for the pharmacy’s name and check its license with your state board of pharmacy. You can also ask the provider what clinical reason went in your chart.

Prices were accurate at the time this was published.

## Sources

- [DailyMed: Wegovy (semaglutide) injection and tablets label](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
- [FDA: FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s](https://www.fda.gov/news-events/press-announcements/fda-warns-30-telehealth-companies-against-illegal-marketing-compounded-glp-1s)
- [FDA: What to Know When Promoting Compounded Drugs](https://www.fda.gov/drugs/human-drug-compounding/fda-telehealth-companies-what-know-when-promoting-compounded-drugs)
- [FDA: FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss)
- [FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize](https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize)
- [Novo Nordisk: Wegovy self-pay savings offer](https://www.novocare.com/obesity/products/wegovy/savings-offer.html)

See what a Living+ plan costs and whether it fits.

[**See treatments and pricing**](https://livingplusrx.com/weight-loss/)

Wegovy is a registered trademark of Novo Nordisk A/S. Living+ is not affiliated with or endorsed by this company.

## Quick answers

### Is compounded semaglutide a generic version of Wegovy?

No. FDA says compounded drugs are not the same as FDA-approved generics, and it has warned telehealth companies against describing them as generic versions of approved drugs.

### Does compounded semaglutide work as well as Wegovy?

Wegovy's trials cannot answer that, because they studied Wegovy. FDA does not review compounded drugs for effectiveness before they are sold, and Wegovy's results should not be applied to them.

### Is compounded semaglutide safe?

FDA does not review compounded drugs for safety or quality before they are marketed. As of May 31, 2026, it had 990 adverse event reports tied to compounded semaglutide, and it notes underreporting is likely. A licensed provider should go over your history and the risks with you.

### Why would a provider prescribe compounded semaglutide instead of Wegovy?

FDA says a compounded drug might be appropriate if a patient's medical need cannot be met by an FDA-approved drug. At Living+, a compounded product is prescribed only when the licensed provider determines an FDA-approved product is not clinically suitable and documents why.